117 related articles for article (PubMed ID: 27519790)
1. A Caenorhabditis elegans model to study dopamine transporter deficiency syndrome.
Illiano P; Lanzo A; Leo D; Paglione M; Zampi G; Gainetdinov RR; Di Schiavi E
Eur J Neurosci; 2017 Jan; 45(1):207-214. PubMed ID: 27519790
[TBL] [Abstract][Full Text] [Related]
2. Sequence determinants of the Caenhorhabditis elegans dopamine transporter dictating in vivo axonal export and synaptic localization.
Robinson SB; Hardaway JA; Hardie SL; Wright J; Glynn RM; Bermingham DP; Han Q; Sturgeon SM; Freeman P; Blakely RD
Mol Cell Neurosci; 2017 Jan; 78():41-51. PubMed ID: 27913309
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological Chaperones of the Dopamine Transporter Rescue Dopamine Transporter Deficiency Syndrome Mutations in Heterologous Cells.
Beerepoot P; Lam VM; Salahpour A
J Biol Chem; 2016 Oct; 291(42):22053-22062. PubMed ID: 27555326
[TBL] [Abstract][Full Text] [Related]
4. Psychomotor impairments and therapeutic implications revealed by a mutation associated with infantile Parkinsonism-Dystonia.
Aguilar JI; Cheng MH; Font J; Schwartz AC; Ledwitch K; Duran A; Mabry SJ; Belovich AN; Zhu Y; Carter AM; Shi L; Kurian MA; Fenollar-Ferrer C; Meiler J; Ryan RM; Mchaourab HS; Bahar I; Matthies HJ; Galli A
Elife; 2021 May; 10():. PubMed ID: 34002696
[TBL] [Abstract][Full Text] [Related]
5. Vigorous motor activity in Caenorhabditis elegans requires efficient clearance of dopamine mediated by synaptic localization of the dopamine transporter DAT-1.
McDonald PW; Hardie SL; Jessen TN; Carvelli L; Matthies DS; Blakely RD
J Neurosci; 2007 Dec; 27(51):14216-27. PubMed ID: 18094261
[TBL] [Abstract][Full Text] [Related]
6. Recombinant Adeno-Associated Virus-mediated rescue of function in a mouse model of Dopamine Transporter Deficiency Syndrome.
Illiano P; Bass CE; Fichera L; Mus L; Budygin EA; Sotnikova TD; Leo D; Espinoza S; Gainetdinov RR
Sci Rep; 2017 Apr; 7():46280. PubMed ID: 28417953
[TBL] [Abstract][Full Text] [Related]
7. Acute blockade of the Caenorhabditis elegans dopamine transporter DAT-1 by the mammalian norepinephrine transporter inhibitor nisoxetine reveals the influence of genetic modifications of dopamine signaling in vivo.
Bermingham DP; Hardaway JA; Snarrenberg CL; Robinson SB; Folkes OM; Salimando GJ; Jinnah H; Blakely RD
Neurochem Int; 2016 Sep; 98():122-8. PubMed ID: 26850478
[TBL] [Abstract][Full Text] [Related]
8. A genetic screen in Caenorhabditis elegans for dopamine neuron insensitivity to 6-hydroxydopamine identifies dopamine transporter mutants impacting transporter biosynthesis and trafficking.
Nass R; Hahn MK; Jessen T; McDonald PW; Carvelli L; Blakely RD
J Neurochem; 2005 Aug; 94(3):774-85. PubMed ID: 15992384
[TBL] [Abstract][Full Text] [Related]
9. The Atypical MAP Kinase SWIP-13/ERK8 Regulates Dopamine Transporters through a Rho-Dependent Mechanism.
Bermingham DP; Hardaway JA; Refai O; Marks CR; Snider SL; Sturgeon SM; Spencer WC; Colbran RJ; Miller DM; Blakely RD
J Neurosci; 2017 Sep; 37(38):9288-9304. PubMed ID: 28842414
[TBL] [Abstract][Full Text] [Related]
10. β-Phenylethylamine requires the dopamine transporter to increase extracellular dopamine in Caenorhabditis elegans dopaminergic neurons.
Hossain M; Wickramasekara RN; Carvelli L
Neurochem Int; 2014 Jul; 73():27-31. PubMed ID: 24161617
[TBL] [Abstract][Full Text] [Related]
11. Pharmacochaperoning in a
Asjad HMM; Kasture A; El-Kasaby A; Sackel M; Hummel T; Freissmuth M; Sucic S
J Biol Chem; 2017 Nov; 292(47):19250-19265. PubMed ID: 28972153
[TBL] [Abstract][Full Text] [Related]
12. Forward genetic analysis to identify determinants of dopamine signaling in Caenorhabditis elegans using swimming-induced paralysis.
Hardaway JA; Hardie SL; Whitaker SM; Baas SR; Zhang B; Bermingham DP; Lichtenstein AJ; Blakely RD
G3 (Bethesda); 2012 Aug; 2(8):961-75. PubMed ID: 22908044
[TBL] [Abstract][Full Text] [Related]
13. Dopamine transporter/syntaxin 1A interactions regulate transporter channel activity and dopaminergic synaptic transmission.
Carvelli L; Blakely RD; DeFelice LJ
Proc Natl Acad Sci U S A; 2008 Sep; 105(37):14192-7. PubMed ID: 18768815
[TBL] [Abstract][Full Text] [Related]
14. Extracellular dopamine and alterations on dopamine transporter are related to reserpine toxicity in Caenorhabditis elegans.
Reckziegel P; Chen P; Caito S; Gubert P; Soares FA; Fachinetto R; Aschner M
Arch Toxicol; 2016 Mar; 90(3):633-45. PubMed ID: 25579234
[TBL] [Abstract][Full Text] [Related]
15. Blockade and reversal of swimming-induced paralysis in C. elegans by the antipsychotic and D2-type dopamine receptor antagonist azaperone.
Refai O; Blakely RD
Neurochem Int; 2019 Feb; 123():59-68. PubMed ID: 29800604
[TBL] [Abstract][Full Text] [Related]
16. Identifying dominant-negative actions of a dopamine transporter variant in patients with parkinsonism and neuropsychiatric disease.
Herborg F; Jensen KL; Tolstoy S; Arends NV; Posselt LP; Shekar A; Aguilar JI; Lund VK; Erreger K; Rickhag M; Lycas MD; Lonsdale MN; Rahbek-Clemmensen T; Sørensen AT; Newman AH; Løkkegaard A; Kjærulff O; Werge T; ; Møller LB; Matthies HJ; Galli A; Hjermind LE; Gether U
JCI Insight; 2021 Sep; 6(18):. PubMed ID: 34375312
[TBL] [Abstract][Full Text] [Related]
17. Dopamine transporter-mediated cytotoxicity of 6-hydroxydopamine in vitro depends on expression of mutant alpha-synucleins related to Parkinson's disease.
Lehmensiek V; Tan EM; Liebau S; Lenk T; Zettlmeisl H; Schwarz J; Storch A
Neurochem Int; 2006 Apr; 48(5):329-40. PubMed ID: 16406146
[TBL] [Abstract][Full Text] [Related]
18. Null allele mutants of trt-1, the catalytic subunit of telomerase in Caenorhabditis elegans, are less sensitive to Mn-induced toxicity and DAergic degeneration.
Ijomone OM; Miah MR; Peres TV; Nwoha PU; Aschner M
Neurotoxicology; 2016 Dec; 57():54-60. PubMed ID: 27593554
[TBL] [Abstract][Full Text] [Related]
19. Protein kinase-mediated bidirectional trafficking and functional regulation of the human dopamine transporter.
Pristupa ZB; McConkey F; Liu F; Man HY; Lee FJ; Wang YT; Niznik HB
Synapse; 1998 Sep; 30(1):79-87. PubMed ID: 9704884
[TBL] [Abstract][Full Text] [Related]
20. Dopaminergic modulation by quercetin: In silico and in vivo evidence using Caenorhabditis elegans as a model.
Salgueiro WG; Soares MV; Martins CF; Paula FR; Rios-Anjos RM; Carrazoni T; Mori MA; Müller RU; Aschner M; Dal Belo CA; Ávila DS
Chem Biol Interact; 2023 Sep; 382():110610. PubMed ID: 37348670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
